LGALS9 and pancreatic ductal adenocarcinoma: Researchers used bone marrow mesenchymal stem-cell-derived exosomes to deliver Galectin 9 siRNA to target pancreatic ductal adenocarcinoma (PDAC) thereby boosting immunotherapy in pancreatic cancer.